artera.aiHealthcareFounded: 2021Funding to Date: $89.5MM
Artera, founded in 2021, is a precision medicine company and the developer of multimodal artificial intelligence-based predictive and prognostic tests with the goal of personalizing therapy for cancer patients. Artera’s flagship test is the ArteraAI Prostate Test, seeking to predict therapy benefit in localized prostate cancer. Artera is headquartered in Los Altos, California.
